Skip to content Skip to footer
Who We Are

Most Validated AI Therapeutic Design Platform

About Us

Ainnocence is a global biotech company that leads in generative AI for therapeutic discovery, leveraging industry grade sequence-based proprietary technology and training data from over 16 years expertise.

Problem:

Costly high throughput wet lab screening, expensive structure biology and inaccurate 3D modeling processes.

Solution:

A radical AI drug discovery system that accelerates the discovery of life-saving therapies with unprecedented speed, large and deep virtual throughput and higher success rates, for all therapeutic targets.

Optimizing Therapeutic Discovery with AI Enabled

Processes Supporting All Modelities

Ainnocence’s discovery platform is a proprietary,
sequence-based AI system developed entirely in-house.

By working directly from primary sequence data, it eliminates the need for external 3-D structure-prediction software and other open-source packages. Instead, our technology performs ultra-high-throughput virtual screening and multi-objective optimisation, evaluating up to 10¹⁰ candidates within hours to days—giving our partners capabilities that off-the-shelf tools cannot match.

Contact Us

Have questions?
Get in touch!

    Empowering Industry Leaders Globally

    Sponsored By AI partners

    Receive News

    Subscribe for the Updates!